文献速递乳房整形与再造创面修复

绵羊增强混合补片(OviTex)在全假体乳房再造中的临床结局

Clinical Outcomes of Ovine-Reinforced Hybrid Mesh (OviTex) in Alloplastic Breast Reconstruction.
PubMed 文献 · Ann Plast Surg · 2026-02-02

再手术率为22%(29侧),主要因假体暴露(20%)、感染(10%)或两者兼有(8%);直接置入假体者和患癌侧再手术风险显著更高(P < 0.001)。

要点

  • 直接置入假体再造的再手术风险显著高于组织扩张器(P < 0.001)。
  • 患癌侧再造的再手术风险显著高于预防性再造(P < 0.001)。
  • 假体置入层次(胸肌前 vs 双平面)与放疗对再手术无显著影响。

核心结论

  • 再手术在直接置入假体再造和患癌侧显著更常见,可能归因于皮瓣灌注而非补片固有特性。
  • 缺乏吲哚菁绿血管造影很可能导致再手术率高于预期。
  • 显著更小的假体可能带来更高的再造成功率。

研究设计与样本

  • 单术者回顾性病历分析,纳入2019至2023年使用OviTex行即时或延期乳房再造且未使用吲哚菁绿血管造影的患者。

主要发现

  • 直接置入假体占65%,组织扩张器占35%;即时再造占97%,延期占3%。
  • 胸肌前放置占72%,双平面占28%。
  • 再手术29侧(22%),全部见于即时再造,主要因暴露(20%)、感染(10%)或两者兼有(8%)。
  • 血清肿4侧(3%),其中2侧因暴露需手术干预;未见血肿。
  • 直接置入假体较组织扩张器再手术风险显著更高(P < 0.001),患癌侧较预防性再造显著更高(P < 0.001)。

临床怎么用

  • 使用OviTex行全假体乳房再造时,应特别关注直接置入假体和患癌侧患者的再手术风险。
  • 即使皮瓣较薄,按计划行即时再造时需警惕灌注不足导致的暴露和感染。
  • 可考虑使用吲哚菁绿血管造影评估皮瓣灌注以降低再手术率。

局限性

  • 单术者回顾性研究,可能存在选择偏倚。
  • 未使用吲哚菁绿血管造影,无法评估灌注对结局的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study examines clinical outcomes of Ovine-Reinforced Hybrid Mesh (OviTex) in alloplastic breast reconstruction by a single surgeon. METHODS: A retrospective chart review was conducted on patients who underwent immediate or delayed breast reconstruction with OviTex between 2019 and 2023 without indocyanine green angiography. Outcomes analyzed included reoperation rates, implant exposure, infection, seroma, and hematoma. Even in patients with thin mastectomy skin flaps, immediate reconstruction was essentially performed whenever planned. RESULTS: Seventy-nine patients (134 breasts) were included. The majority of reconstructions involved direct-to-implant procedures (65% vs 35% tissue expander), with a predominance of immediate reconstructions (97% vs 3% delayed) and prepectoral placement (72% vs 28% dual-plane). Reoperation occurred in 29 breasts (22%), all in immediate reconstructions, primarily due to exposure (20%), infection (10%), or a combination of both (8%). Four breasts (3%) developed a seroma, two of which also required surgical intervention for exposure. No hematomas were observed. Reoperation was significantly more likely on breasts treated direct-to-implant compared to those with tissue expanders ( P < 0.001) and on the cancer side compared to prophylactic reconstructions ( P < 0.001). No significant differences in reoperation were noted regarding placement location (prepectoral vs dual-plane) or radiation treatment. CONCLUSION: This study provides clinical outcomes on OviTex use in alloplastic breast reconstruction. Reoperation was significantly more likely in direct-to-implant reconstruction and on the side with cancer, likely due to skin flap perfusion rather than intrinsic mesh properties. The lack of access to indocyanine green angiography, as others have reported, in all likelihood contributed to the higher-than-expected rate of reoperation. In addition, significantly smaller implants might have led to a higher rate of reconstructive success.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Paliwoda ED, Shihadeh H, Awad AN, et al. Clinical Outcomes of Ovine-Reinforced Hybrid Mesh (OviTex) in Alloplastic Breast Reconstruction. Ann Plast Surg. 2026. PMID: 41628405. doi:10.1097/SAP.0000000000004624

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。